Nemolizumab: all 26 studies that test it
Page 1 of 1. Open to participants first (7), then studies with results posted, then the rest; newest registration first within each.
- Nemolizumab for the Treatment of Moderate to Severe Chronic Hepatic PruritusNot yet recruitingNCT07843420Phase 2
- Randomized, Double-blind, Placebo-controlled Study of Nemolizumab in Chinese Subjects With Moderate-to-severe Atopic DermatitisRecruitingNCT07762833Phase 3
- Nemolizumab for LSNot yet recruitingNCT07704775Phase 2
- Pharmacokinetics, Safety and Efficacy of Nemolizumab in Participants Aged 6 to 23 Months With Moderate-to Severe Atopic DermatitisRecruitingNCT07660835Phase 2
- Nemolizumab to Treat Lichen Planopilaris, a Noncontrolled, Prospective, Pilot Study.RecruitingNCT07396168Phase 4
- Utilization of a Microdevice for Psoriasis and Atopic DermatitisNot yet recruitingNCT07352566Phase 4
- A Study of Nemolizumab for the Treatment of Adults With Systemic SclerosisRecruitingNCT07047690Phase 2
- Study to Access the Relative Bioavailability of Subcutaneous Dose of Nemolizumab When Administered Via Auto-Injector Versus Dual-Chamber SyringeCompletedNCT05405985Phase 1Results posted
- An Open-label, Phase 2 Study to Assess the Efficacy and Safety of Nemolizumab in Subjects With Systemic SclerosisCompletedNCT05214794Phase 2Results posted
- To Evaluate the Efficacy and Safety of Nemolizumab for 12 Weeks in Participants With Chronic Kidney Disease With Associated Moderate to Severe PruritusCompletedNCT05075408Phase 2/3Results posted
- A Study to Evaluate the Durability of Response and Safety of Nemolizumab for 24 Weeks in Participants With Prurigo NodularisCompletedNCT05052983Phase 3Results posted
- Pharmacokinetics, Safety and Efficacy of Nemolizumab in Participants With Moderate-to-Severe Atopic DermatitisCompletedNCT04921345Phase 2Results posted
- A Study to Assess the Effects of Nemolizumab on Cytochrome P450 Substrates in Participants With Moderate-to-Severe Atopic DermatitisCompletedNCT04562116Phase 2Results posted
- A Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)CompletedNCT04501679Phase 3Results posted
- Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)CompletedNCT04501666Phase 3Results posted
- A Study to Assess Immunization Responses in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Treated With NemolizumabCompletedNCT04365387Phase 2Results posted
- Efficacy & Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic DermatitisCompletedNCT03989349Phase 3Results posted
- Efficacy and Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic DermatitisCompletedNCT03985943Phase 3Results posted
- A Pharmacokinetics and Safety Study of Nemolizumab in Adolescent Participants With Atopic Dermatitis (AD)CompletedNCT03921411Phase 2Results posted
- Safety and Efficacy of Nemolizumab in PNCompletedNCT03181503Phase 2Results posted
- Dose-ranging Study of Nemolizumab in Atopic DermatitisCompletedNCT03100344Phase 2Results posted
- A Phase 2 Study of CIM331 for Atopic Dermatitis PatientsCompletedNCT01986933Phase 2Results posted
- Proof of Concept Study to Assess the Pharmacokinetics/Pharmacodynamics of Nemolizumab in Adults With Chronic Pruritus of Unknown Origin (CPUO)Active, not recruitingNCT07074977Phase 2
- Efficacy and Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis With Inadequate Response to or for Whom Cyclosporine A is Not Medically AdvisableWithdrawnNCT05056779Phase 3
- A Long-term Study of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)Active, not recruitingNCT04204616Phase 3
- Long-term Safety and Efficacy of Nemolizumab With Moderate-to-severe Atopic DermatitisCompletedNCT03989206Phase 3